SCHEMBL1660158

SCHEMBL1660158

Cc1ccccc1SCC(=O)O

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.61
FFAR1 O14842 1/20 0.55
KDM4E B2RXH2 3/20 0.50
CDC25B P30305 2/20 0.50
S100A4 P26447 1/20 0.50
NOTUM Q6P988 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
HSD17B10 Q99714 2/20 0.47
ALDH1A1 P00352 2/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
NPC1 O15118 1/20 0.45
POLB P06746 1/20 0.45
HSP90AA1 P07900 1/20 0.45
RAB9A P51151 1/20 0.45
GAA P10253 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14273063 0.85 CYP1A2 (0.73) CYP1A2FFAR1KDM4ECDC25BS100A4
SCHEMBL1661817 0.85 CYP1A2 (0.53) CYP1A2FFAR1KDM4ECDC25BS100A4
SCHEMBL27044925 0.84 NOTUM (0.50) CYP1A2KDM4ENOTUMSMN1; SMN2HSD17B10
SCHEMBL11215817 0.82 ALDH1A1 (0.52) NOTUMSMN1; SMN2HSD17B10ALDH1A1MAPT
SCHEMBL7223998 0.82 NOTUM (0.49) CYP1A2KDM4ENOTUMSMN1; SMN2HSD17B10
SCHEMBL11215814 0.82 NOTUM (0.49) CYP1A2KDM4ENOTUMSMN1; SMN2HSD17B10
SCHEMBL5637483 0.81 SMN1; SMN2 (0.56) KDM4ECDC25BS100A4SMN1; SMN2HSD17B10
SCHEMBL14557232 0.80 CYP1A2 (0.61) CYP1A2FFAR1KDM4ECDC25BS100A4
SCHEMBL2059519 0.79 FFAR1 (0.54) CYP1A2FFAR1CDC25BS100A4SMN1; SMN2
SCHEMBL21328440 0.78 CYP1A2 (0.59) CYP1A2FFAR1KDM4ECDC25BS100A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 330 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12552888-B2 Curable resin composition and display device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-02-17 US disclosed
US-12528983-B2 Curable resin composition and display device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2026-01-20 US disclosed
US-12504564-B2 Layered body and display device SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2025-12-23 US disclosed
CN-120077106-A Curable composition, cured film, and display device 住友化学株式会社 2025-05-30 CN disclosed
EP-4559971-A1 COMPOSITION, FILM, AND DISPLAY DEVICE Sumitomo Chemical Company, Limited (JP) 2025-05-28 EP disclosed
US-20250155803-A1 CURABLE COMPOSITION, CURED FILM, AND DISPLAY DEVICE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2025-05-15 US disclosed
CN-113264918-B Coloring composition, compound, color filter and display device 住友化学株式会社 2025-04-22 CN disclosed
CN-112835260-B Photosensitive resin composition, color filter using the same and display device 住华科技股份有限公司 2025-04-18 CN disclosed
CN-116323713-B Curable composition and cured film 住友化学株式会社 2025-04-11 CN disclosed
CN-119816544-A Composition, cured product, display device, and solid-state imaging device 住友化学株式会社 2025-04-11 CN disclosed
CN-104298075-A Colored photosensitive resin composition, color filter and display device comprising the same DONGWOO FINE CHEM CO LTD 2015-01-21 CN disclosed
CN-104298073-A Colored curable resin composition SUMITOMO CHEMICAL CO 2015-01-21 CN disclosed
CN-104298074-A Photosensitive resin composition for formation of transparent pixel, and color filler formed by using photosensitive resin composition DONGWOO FINE CHEM CO LTD 2015-01-21 CN disclosed
CN-104298072-A Colored curable resin composition SUMITOMO CHEMICAL CO 2015-01-21 CN disclosed
US-20110112266-A1 CURABLE COPOLYMER AND CURABLE RESIN COMPOSITION DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2011-05-12 US disclosed
EP-2308905-A1 CURABLE COPOLYMER AND CURABLE RESIN COMPOSITION Daicel Chemical Industries, Ltd. (JP) 2011-04-13 EP disclosed
US-7335466-B2 Silver salt photothermographic dry imaging material, image recording method and image forming method for the same KONICA MINOLTA HOLDINGS, INC. (JP) 2008-02-26 US disclosed
WO-2003057161-A2 BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-17 WO disclosed
US-4086240-A 1-Thiazolyl-5-phenoxy and phenylthioalkanoyloxyimidazolidinones VELSICOL CHEMICAL CORPORATION (US) 1978-04-25 US disclosed
US-4053480-A 1-THIADIAZOLYL-5-PHENOXY- AND PHENYLTHIOALKANOYLOXY IMIDAZOLIDINONES VELSICOL CHEMICAL CORPORATION (US) 1977-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12552888-B2 Curable resin composition and display device RAD51, LPO, FTO CYP1A2 4252/4885FFAR1 1386/4885KDM4E 12/4885
US-12528983-B2 Curable resin composition and display device TIPRL, NLRP1, RCSD1 CYP1A2 3764/4885FFAR1 1538/4885KDM4E 1136/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.